antibody-IFN lambda conjugates (Immunomedics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameantibody-IFN lambda conjugates (Immunomedics)

Drug Alias Name(15)-lambda 1humanized hL243 antibody-IFN lambda 1 conjugate (Immunomedics)humanized hRS7 antibody-IFN lambda 1 conjugate (Immunomedics)(E1)-lambda 1humanized hMN-15 antibody-IFN lambda 1 conjugate (Immunomedics) +[6]

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionInterferon lambda receptor stimulants

TargetsInterferon lambda receptor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesImmunomedics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesImmunomedics Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A